Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(43%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
4
57%
Ph not_applicable
1
14%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(1)
Other(3)

Detailed Status

unknown3
Recruiting2
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 24 (80.0%)
N/A1 (20.0%)

Trials by Status

completed114%
recruiting229%
active_not_recruiting114%
unknown343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
PROCEDURE
Total Trials
7